BPG is committed to discovery and dissemination of knowledge
Article Citation
Yang HH, Huang Y, Zhou XC, Wang RN. Efficacy and safety of adalimumab in comparison to infliximab for Crohn's disease: A systematic review and meta-analysis. World J Clin Cases 2022; 10(18): 6091-6104 [PMID: 35949827 DOI: 10.12998/wjcc.v10.i18.6091]
Please LOGIN to submit a new comment.
Write to the Help Desk